INSIDER · CIK 1598549
Schwab Andrew J.
Director, 10% Owner at Skye Bioscience, Inc. (SKYE) · Director at Camp4 Therapeutics Corp (CAMP)
↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.8MSold on the market
2Companies
Sep 24, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 202616:31 | Sep 23, 2026from Sep 22, 2026 | SKYESkye Bioscience, Inc. | Director, 10% Owner | S · Sell | $1.62 | −148,079 | 0 | -100% | −$240K | ||
| Sep 18, 202618:39 | Sep 16, 2026 | SKYESkye Bioscience, Inc. | Director, 10% Owner | S · Sell | $1.91 | −33,892 | 5,616 | -86% | −$65K | ||
| Aug 31, 202617:05 | Aug 27, 2026 | CAMPCamp4 Therapeutics Corp | Director | S · Sell | $4.04 | −400,000 | 2,033,270 | -16% | −$1.6M | ||
| Aug 26, 202616:57 | Aug 24, 2026 | CAMPCamp4 Therapeutics Corp | Director | S · Sell | $4.50 | −10 | 2,433,270 | -0% | −$45.00 | ||
| Aug 21, 202616:59 | Aug 21, 2026from Aug 19, 2026 | CAMPCamp4 Therapeutics Corp | Director | S · Sell | $4.59 | −191,865 | 2,433,280 | -7% | −$880K | ||
| Aug 20, 202617:59 | Aug 20, 2026from Aug 18, 2026 | SKYESkye Bioscience, Inc. | Director, 10% Owner | S · SellPrice unverified | $0.37 | −375,840 | 7,850,155 | -5% | — |